Science Explorer Back to mapMap
Discussion
Company · Hamburg · Germany

Evotec (Germany)

World rank, all time
#16,676
of 34,923
Rank in Germany
#834
of 1,603
Research works
187
▲ 144% vs 2018-21
Citations
5.3k
28.3 per fractional work
Top-10% rate
12.5%
all institutions 10.0%
vs its own fields
1.02×
1.00× is exactly expected
Open access
44%
world 40%
International
50%
world 18%

Which fields of science does Evotec (Germany) work in?

In 2022-now, 48% of research at Evotec (Germany) is in Health Sciences, 45% in Life Sciences. Its largest fields are Medicine (48%), Biochemistry, Genetics and Molecular Biology (34%), Immunology and Microbiology (5%). It does 2.7× the world's share of Life Sciences.

Health Sciences: 26 fractional works · 48.1% of its workMedicine: 25 fractional works · 47.7% of its workNephrology: 7 fractional works · 12.6% of its workOncology: 3 fractional works · 5.3% of its workCardiology and Cardiovascular Medicine: 2 fractional works · 3.9% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 3.7% of its workPulmonary and Respiratory Medicine: 2 fractional works · 3.5% of its workPhysiology: 1 fractional works · 2.7% of its workRheumatology: 1 fractional works · 2.2% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.7% of its workSurgery: 1 fractional works · 1.6% of its workEpidemiology: 1 fractional works · 1.4% of its workInfectious Diseases: 1 fractional works · 1.4% of its workNeurology: 1 fractional works · 1.2% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 1.0% of its workPharmacology: 0 fractional works · 0.9% of its workGenetics: 0 fractional works · 0.9% of its workGastroenterology: 0 fractional works · 0.7% of its workHepatology: 0 fractional works · 0.6% of its workImmunology and Allergy: 0 fractional works · 0.5% of its workPsychiatry and Mental health: 0 fractional works · 0.3% of its workReproductive Medicine: 0 fractional works · 0.3% of its workPathology and Forensic Medicine: 0 fractional works · 0.3% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.2% of its workBiochemistry: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workVeterinary: 0 fractional works · 0.2% of its workSmall Animals: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 0.1% of its workNursing: 0 fractional works · 0.1% of its workLife Sciences: 24 fractional works · 44.7% of its workBiochemistry, Genetics and Molecular Biology: 18 fractional works · 34.3% of its workMolecular Biology: 14 fractional works · 26.0% of its workCancer Research: 1 fractional works · 2.6% of its workBiotechnology: 1 fractional works · 2.0% of its workCell Biology: 1 fractional works · 1.5% of its workGenetics: 1 fractional works · 1.3% of its workPhysiology: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.4% of its workImmunology and Microbiology: 3 fractional works · 5.2% of its workImmunology: 3 fractional works · 5.0% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 2 fractional works · 3.7% of its workCellular and Molecular Neuroscience: 1 fractional works · 2.7% of its workSensory Systems: 0 fractional works · 0.4% of its workCognitive Neuroscience: 0 fractional works · 0.3% of its workBiological Psychiatry: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 1.0% of its workPlant Science: 0 fractional works · 0.5% of its workAnimal Science and Zoology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.5% of its workPharmacology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysical Sciences: 3 fractional works · 6.4% of its workChemistry: 1 fractional works · 2.0% of its workOrganic Chemistry: 1 fractional works · 1.7% of its workSpectroscopy: 0 fractional works · 0.3% of its workComputer Science: 1 fractional works · 1.2% of its workComputational Theory and Mathematics: 1 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEngineering: 1 fractional works · 1.2% of its workBiomedical Engineering: 1 fractional works · 1.2% of its workEnvironmental Science: 1 fractional works · 1.1% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 0 fractional works · 0.7% of its workMaterials Chemistry: 0 fractional works · 0.4% of its workBiomaterials: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 0.8% of its workSocial Sciences: 0 fractional works · 0.6% of its workHealth: 0 fractional works · 0.6% of its workArts and Humanities: 0 fractional works · 0.1% of its workPsychology: 0 fractional works · 0.1% of its workALL ITS WORKEvotec (Germany)53fractional works, 2022-now
Life Sciences45%Physical Sciences6%Health Sciences48%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 20 fields, with their numbers
    1. Medicine2547.7%
    2. Veterinary00.2%
    3. Health Professions00.1%
    4. Nursing00.1%
    1. Biochemistry, Genetics and Molecular Biology1834.3%
    2. Immunology and Microbiology35.2%
    3. Neuroscience23.7%
    4. Agricultural and Biological Sciences11.0%
    5. Pharmacology, Toxicology and Pharmaceutics00.5%
    1. Chemistry12.0%
    2. Computer Science11.2%
    3. Engineering11.2%
    4. Environmental Science11.1%
    5. Materials Science00.7%
    6. Physics and Astronomy00.2%
    1. Social Sciences00.6%
    2. Arts and Humanities00.1%
    3. Psychology00.1%
    4. Decision Sciences00.0%
    5. Economics, Econometrics and Finance00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.20× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 6.44× its world share, 18 worksBiochemistry, Geneti…Immunology and Microbiology: 5.20× its world share, 3 worksImmunology and Micro…Neuroscience: 2.31× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.33× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.30× its world share, 1 worksChemistryComputer Science: 0.16× its world share, 1 worksComputer ScienceEngineering: 0.08× its world share, 1 worksEngineeringEnvironmental Science: 0.21× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.19× its world share, 0 worksMaterials SciencePhysics and Astronomy: 0.08× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.05× its world share, 0 worksHealth ProfessionsMedicine: 2.48× its world share, 25 worksMedicineNursing: 0.21× its world share, 0 worksNursingVeterinary: 1.54× its world share, 0 worksVeterinaryArts and Humanities: 0.02× its world share, 0 worksArts and HumanitiesDecision Sciences: 0.01× its world share, 0 worksDecision SciencesPsychology: 0.02× its world share, 0 worksPsychologySocial Sciences: 0.05× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.4×. Every wedge is a field page.

All 19 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology6.44×18 works
  2. Immunology and Microbiology5.20×3 works
  3. Medicine2.48×25 works
  4. Neuroscience2.31×2 works
  5. Veterinary1.54×0 works
  6. Pharmacology, Toxicology and Pharmaceutics1.33×0 works
  7. Chemistry1.30×1 works
  8. Environmental Science0.21×1 works
  9. Nursing0.21×0 works
  10. Agricultural and Biological Sciences0.20×0 works
  11. Materials Science0.19×0 works
  12. Computer Science0.16×1 works
  13. Engineering0.08×1 works
  14. Physics and Astronomy0.08×0 works
  15. Health Professions0.05×0 works
  16. Social Sciences0.05×0 works
  17. Arts and Humanities0.02×0 works
  18. Psychology0.02×0 works
  19. Decision Sciences0.01×0 works

Who are the top researchers at Evotec (Germany)?

Ranked on the quality score, Kirsten Kuhlbrodt, Swathi Sujatha-Bhaskar and Robert Godemann lead among researchers whose main affiliation is Evotec (Germany).

  1. 1 Kirsten Kuhlbrodt Germany · #607,797 worldwide 3k citations · 19 works
  2. 2 Swathi Sujatha-Bhaskar Germany · #1,103,200 worldwide 738 citations · 16 works
  3. 3 Robert Godemann Germany · #1,144,632 worldwide 2k citations · 19 works
  4. 4 Georgette M. Castanedo Germany · #1,302,951 worldwide 2.1k citations · 56 works
  5. 5 Allan Jaochico Germany · #1,465,704 worldwide 509 citations · 17 works
  6. 6 Felix S. Oppermann Germany · #1,484,409 worldwide 1.5k citations · 27 works
  7. 7 Klaus Godl Germany · #1,506,259 worldwide 1.9k citations · 44 works
  8. 8 Alexander Böcker Germany · #1,764,741 worldwide 956 citations · 24 works
  9. 9 Heinz von der Kammer Germany · #1,824,350 worldwide 1.1k citations · 20 works
  10. 10 Rainer Netzer Germany · #1,863,278 worldwide 858 citations · 15 works
All ranked researchers at Evotec (Germany)

What are the most cited papers from Evotec (Germany)?

The most cited paper from Evotec (Germany) is "Ionotropic and metabotropic glutamate receptor structure and pharmacology" (James N.C. Kew, John A. Kemp, 2005), with 788 citations. Next come "Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology" (785) and "NMDA receptor pathways as drug targets" (480).

Most cited papers
#PaperReleasedCitations
1 Ionotropic and metabotropic glutamate receptor structure and pharmacology James N.C. Kew, John A. Kemp · Psychopharmacology 24 Feb 2005 788
2 Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology Claire Bridel et al. · JAMA Neurology Open access 17 Jun 2019 785
3 NMDA receptor pathways as drug targets John A. Kemp, Ruth M. McKernan · Nature Neuroscience 28 Oct 2002 480
4 Integrated genomics and proteomics define huntingtin CAG length–dependent networks in mice Peter Langfelder et al. · Nature Neuroscience Open access 22 Feb 2016 463
5 Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS–SOS1 interaction Roman Christian Hillig et al. · Proceedings of the National Academy of Sciences Open access 25 Jan 2019 385
All 60 most cited papers, with filters and sorting

Which keywords describe research at Evotec (Germany)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Glomerular Diseases, Nephrotic Syndrome, Immunotherapy, Cancer, Cardiovascular Disease, Fibrosis, Inflammation and Cancer Immunotherapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer4▲ 6.1×16 topics
  2. Inflammation4▲ 3.9×20 topics
  3. Cardiovascular Disease4▲ 6.7×9 topics
  4. Glomerular Diseases4▲ 233×1 topic
  5. Immunotherapy4▲ 10×6 topics
  6. Nephrotic Syndrome4▲ 233×1 topic
  7. Fibrosis3▲ 32×4 topics
  8. Biomarkers3▲ 7.8×6 topics
  9. Cancer Immunotherapy3▲ 36×3 topics
  10. Chronic Kidney Disease3▲ 20×3 topics
  11. Gene Expression3▲ 7.9×7 topics
  12. Oxidative Stress2▲ 2.9×13 topics
  13. Treatment2▲ 3.5×8 topics
  14. Diabetic Nephropathy2▲ 62×1 topic
  15. Global Burden2▲ 7.6×2 topics
  16. Glomerular Filtration Rate2▲ 93×1 topic
  17. TGF-ß2▲ 26×2 topics
  18. Tumor Regression2▲ 36×2 topics
  19. Biogenesis2▲ 21×3 topics
  20. Pluripotent Stem Cells2▲ 68×2 topics
  21. Data Integration2▲ 20×2 topics
  22. Immunity2▲ 8.2×4 topics
  23. Metabolic Syndrome2▲ 4.3×6 topics
  24. RNA-Seq2▲ 28×2 topics
  25. Clinical Guidelines2▲ 11×3 topics
  26. Single-Cell2▲ 60×1 topic
  27. Transcriptional Regulation2▲ 20×5 topics
  28. Transcriptomics2▲ 60×1 topic
  29. CAR T Cells2▲ 42×1 topic
  30. Chimeric Antigen Receptor2▲ 42×1 topic
  31. Mitochondrial Dysfunction2▲ 11×4 topics
  32. Exosomes2▲ 46×1 topic
  33. Extracellular Vesicles2▲ 46×1 topic
  34. Genetic Mutations2▲ 6.6×3 topics
  35. Prognostic Factors2▲ 6.4×2 topics
  36. Molecular Characterization1▲ 15×2 topics
  37. Calcium Signaling1▲ 30×3 topics
  38. Glycosylation1▲ 21×3 topics
  39. Ion Channels1▲ 20×3 topics
  40. Macrophages1▲ 11×4 topics

Which research topics does Evotec (Germany) publish most on?

By volume in 2022-now: Renal Diseases and Glomerulopathies, Chronic Kidney Disease and Diabetes, Single-cell and spatial transcriptomics and CAR-T cell therapy research.

  1. 1 Renal Diseases and Glomerulopathies Nephrology 4 works
  2. 2 Chronic Kidney Disease and Diabetes Nephrology 2 works
  3. 3 Single-cell and spatial transcriptomics Molecular Biology 2 works
  4. 4 CAR-T cell therapy research Oncology 2 works
  5. 5 Extracellular vesicles in disease Molecular Biology 2 works
  6. 6 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 1 works
  7. 7 Renal and related cancers Molecular Biology 1 works
  8. 8 Birth, Development, and Health Pediatrics, Perinatology and Child Health 1 works
  9. 9 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  10. 10 Pluripotent Stem Cells Research Molecular Biology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.5%not open55.5%

World: 40% of research is openly available.

with international co-authors49.5%domestic only50.5%

World: 18% is written across borders.

How has Evotec (Germany)'s research output changed?

Output in 2022-2025 was 144% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Evotec (Germany) as a percentage of every work published that year, 0.00020% in 2024.

still counting0.00020%0.00040%0.00060%Evotec (Germany)0.00021% in 2025200020102020

Fractional works of Evotec (Germany) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Hamburg

All research institutions in Hamburg

Share Evotec (Germany)'s ranking

Evotec (Germany) on Science Explorer

A card with Evotec (Germany)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Evotec (Germany). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.